Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

NCT00893867 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

446

Enrollment

INDUSTRY

Sponsor class

Stopped The result of a pre-planned interim futility analysis

Conditions

Acute Ischemic Stroke

Interventions

DRUG: DP-b99
DRUG: Placebo

Sponsor

D-Pharm Ltd.